C Frank Bennett sold $222k of IONS
EVP, Chief Scientific Officer at IONIS PHARMACEUTICALS INC. 6,752 shares at an average of $32.90, traded Jan 16, 2025, filed Jan 17, 2025.
Score components
- +15RoleOfficer
- +12Trade size$222k at market
- 0Share of holdings soldSold 6.9% of holdings
- +15Cluster10 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0000874015-25-000056, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jan 15, 2025 | MOption exercise Common Stock | +18,011 | $0.00 | $0 | 97,618 | Jan 17, 2025 |
| Jan 16, 2025 | SOpen-market sale Common Stock | -6,752 | $32.90 | $222k | 90,866 | Jan 17, 2025 |
| Jan 15, 2025 | AGrant or award Performance Restricted Stock Unitsderivative | +22,000 | $0.00 | $0 | 63,482 | Jan 17, 2025 |
| Jan 15, 2025 | AGrant or award Restricted Stock Unitderivative | +33,000 | $0.00 | $0 | 56,500 | Jan 17, 2025 |
| Jan 15, 2025 | MOption exercise Restricted Stock Unitderivative | -18,011 | $0.00 | $0 | 38,489 | Jan 17, 2025 |
Related signals
Other insiders at IONIS PHARMACEUTICALS INC and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 33Weak | IONIS PHARMACEUTICALS INC | C Frank Bennett EVP, Chief Scientific Officer | $6.7M 85,089 shares | -51% | |
| 11Weak | IONIS PHARMACEUTICALS INC | Joseph Baroldi EVP, Chief Business Officer | $531k 6,659 shares | -15% | |
| 40Moderate | IONIS PHARMACEUTICALS INC | C Frank Bennett EVP, Chief Scientific Officer | $7.1M 85,089 shares | -85% | |
| 48Moderate | IONIS PHARMACEUTICALS INC | C Frank Bennett EVP, Chief Scientific Officer | $488k 5,885 shares | -6% | |
| 52Moderate | IONIS PHARMACEUTICALS INC | Joseph Baroldi EVP, Chief Business Officer | $439k 5,296 shares | -10% | |
| 48Moderate | IONIS PHARMACEUTICALS INC | Brian Birchler EVP, Corp and Development Ops | $513k 6,179 shares | -9% | |
| 35Weak | IONIS PHARMACEUTICALS INC | C Frank Bennett EVP, Chief Scientific Officer | $675k 8,977 shares | -9% | |
| 40Moderate | IONIS PHARMACEUTICALS INC | Joseph Baroldi EVP, Chief Business Officer | $610k 8,056 shares | -17% | |
| 40Moderate | IONIS PHARMACEUTICALS INC | Brian Birchler EVP, Corp and Development Ops | $637k 8,480 shares | -12% | |
| 45Moderate | IONIS PHARMACEUTICALS INC | Joseph H Wender director | $2.3M 28,000 shares | -44% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.